A review of prognostic and predictive biomarkers in breast cancer

E Tarighati, H Keivan, H Mahani - Clinical and experimental medicine, 2023 - Springer
Breast cancer (BC) is a common cancer all over the world that affects women. BC is one of
the leading causes of cancer mortality in women, which today has decreased with the …

Classic and new markers in diagnostics and classification of breast cancer

R Beňačka, D Szabóová, Z Guľašová, Z Hertelyová… - Cancers, 2022 - mdpi.com
Simple Summary With ever-increasing incidence, breast cancer is considered a most
diagnosed type of cancer among women worldwide. Breast cancer arises through malignant …

Transcription factors in cancer development and therapy

K Vishnoi, N Viswakarma, A Rana, B Rana - Cancers, 2020 - mdpi.com
Cancer is a multi-step process and requires constitutive expression/activation of
transcription factors (TFs) for growth and survival. Many of the TFs reported so far are critical …

Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic …

J Yu, Q Mu, M Fung, X Xu, L Zhu, RJY Ho - Pharmacology & therapeutics, 2022 - Elsevier
Despite advances in breast cancer treatments and related 5-year survival outcomes,
metastatic breast cancer cures remain elusive. The current standard of care includes a …

Progesterone action in breast, uterine, and ovarian cancers

CH Diep, AR Daniel, LJ Mauro… - Journal of …, 2015 - jme.bioscientifica.com
Progesterone and progesterone receptors (PRs) are essential for the development and
cyclical regulation of hormone-responsive tissues including the breast and reproductive …

Progesterone signaling and uterine fibroid pathogenesis; molecular mechanisms and potential therapeutics

M Ali, M Ciebiera, S Vafaei, S Alkhrait, HY Chen… - Cells, 2023 - mdpi.com
Uterine fibroids (UFs) are the most important benign neoplastic threat to women's health
worldwide, with a prevalence of up to 80% in premenopausal women, and can cause heavy …

Estrogen receptors-mediated apoptosis in hormone-dependent cancers

A Chimento, A De Luca, P Avena, F De Amicis… - International journal of …, 2022 - mdpi.com
It is known that estrogen stimulates growth and inhibits apoptosis through estrogen receptor
(ER)-mediated mechanisms in many cancer cell types. Interestingly, there is strong evidence …

Progesterone receptor membrane component 1 promotes the growth of breast cancers by altering the phosphoproteome and augmenting EGFR/PI3K/AKT signalling

DA Pedroza, V Rajamanickam, R Subramani… - British journal of …, 2020 - nature.com
Background Increased expression of the progesterone receptor membrane component 1
(PGRMC1) has been linked to multiple cancers, including breast cancer. Despite being a …

Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer

H Singhal, ME Greene, G Tarulli, AL Zarnke… - Science …, 2016 - science.org
The functional role of progesterone receptor (PR) and its impact on estrogen signaling in
breast cancer remain controversial. In primary ER+ (estrogen receptor–positive)/PR+ human …

[HTML][HTML] Unveiling the role of hormonal imbalance in breast cancer development: A comprehensive review

S Satpathi, SS Gaurkar, A Potdukhe, MB Wanjari - Cureus, 2023 - ncbi.nlm.nih.gov
Breast cancer is a complex and multifactorial disease with a significant global impact.
Hormonal imbalance has emerged as a crucial factor in breast cancer development …